Disclosure About Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements of Assets, Liabilities and Noncontrolling Interests

The following table sets forth our assets and liabilities and the Company’s noncontrolling interests in the Operating Partnership that are measured or disclosed at fair value within the fair value hierarchy:

			Level 1		Level 2
	Total		Quoted Prices in Active Markets for Identical Assets or Liabilities		Significant Observable Inputs
Fair Value at March 31, 2022:
Assets:
Mortgages and notes receivable, at fair value (1)	$	1,203	$	—	$	1,203
Marketable securities of non-qualified deferred compensation plan (in prepaid expenses and other assets)	2,721		2,721		—
Total Assets	$	3,924	$	2,721	$	1,203
Noncontrolling Interests in the Operating Partnership	$	114,570	$	114,570	$	—
Liabilities:
Mortgages and notes payable, net, at fair value (1)	$	2,765,393	$	—	$	2,765,393
Non-qualified deferred compensation obligation (in accounts payable, accrued expenses and other liabilities)	2,721		2,721		—
Total Liabilities	$	2,768,114	$	2,721	$	2,765,393

Fair Value at December 31, 2021:
Assets:
Mortgages and notes receivable, at fair value (1)	$	1,227	$	—	$	1,227
Marketable securities of non-qualified deferred compensation plan (in prepaid expenses and other assets)	2,866		2,866		—
Total Assets	$	4,093	$	2,866	$	1,227
Noncontrolling Interests in the Operating Partnership	$	111,689	$	111,689	$	—
Liabilities:
Mortgages and notes payable, net, at fair value (1)	$	2,907,492	$	—	$	2,907,492
Interest rate swaps (in accounts payable, accrued expenses and other liabilities)	60		—		60
Non-qualified deferred compensation obligation (in accounts payable, accrued expenses and other liabilities)	2,866		2,866		—
Total Liabilities	$	2,910,418	$	2,866	$	2,907,552

__________

(1)    Amounts are not recorded at fair value on our Consolidated Balance Sheets at March 31, 2022 and December 31, 2021.